A detailed history of Altium Wealth Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Altium Wealth Management LLC holds 29,395 shares of AZN stock, worth $2.27 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
29,395
Previous 24,456 20.2%
Holding current value
$2.27 Million
Previous $1.62 Million 19.73%
% of portfolio
0.14%
Previous 0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

BUY
$59.26 - $71.14 $292,685 - $351,360
4,939 Added 20.2%
29,395 $1.94 Million
Q1 2022

May 16, 2022

BUY
$55.72 - $67.12 $181,591 - $218,744
3,259 Added 15.37%
24,456 $1.62 Million
Q4 2021

Jan 31, 2022

BUY
$54.02 - $63.83 $148,825 - $175,851
2,755 Added 14.94%
21,197 $1.24 Million
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $57,893 - $63,343
1,042 Added 5.99%
18,442 $1.11 Million
Q2 2021

Aug 13, 2021

BUY
$48.42 - $60.18 $214,403 - $266,477
4,428 Added 34.14%
17,400 $1.04 Million
Q1 2021

May 06, 2021

BUY
$47.16 - $54.44 $226,226 - $261,148
4,797 Added 58.68%
12,972 $645,000
Q4 2020

Feb 04, 2021

SELL
$48.52 - $58.02 $115,380 - $137,971
-2,378 Reduced 22.53%
8,175 $409,000
Q3 2020

Oct 26, 2020

BUY
$53.07 - $61.1 $13,055 - $15,030
246 Added 2.39%
10,553 $578,000
Q2 2020

Jul 31, 2020

BUY
$43.1 - $55.31 $114,602 - $147,069
2,659 Added 34.77%
10,307 $545,000
Q1 2020

Apr 23, 2020

BUY
$37.79 - $51.33 $289,017 - $392,571
7,648 New
7,648 $342,000
Q4 2018

Jan 18, 2019

SELL
$36.86 - $41.49 $217,326 - $244,625
-5,896 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$34.76 - $39.72 $49,498 - $56,561
-1,424 Reduced 19.45%
5,896 $233,000
Q2 2018

Aug 14, 2018

BUY
$34.55 - $37.05 $252,905 - $271,206
7,320 New
7,320 $257,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $239B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Altium Wealth Management LLC Portfolio

Follow Altium Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altium Wealth Management LLC with notifications on news.